-transparent.png){kind=logo}
A case in which digoxin-like immunoreactive factors (DLIF) interfered with an enzyme immunoassay in a patient with renal insufficiency is reported. A 79-year-old woman was found to have a serum digoxin concentration (SDC) determined by enzyme immunoassay of 5.0 ng/ml. Although all subsequent SDC determined by the enzyme immunoassay system were elevated, identical samples run on a fluorescence polarization immunoassay revealed SDC within the therapeutic range. Marked DLIF-related assay interference has been reported to occur with some digoxin assays; however, the enzyme immunoassay methods have never been reported to cross-react to the magnitude seen in this case.
Related Publications
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
June 1998,
Clinical chemistry,
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
April 1995,
Therapeutic drug monitoring,
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
July 1990,
Harefuah,
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
November 1989,
Therapeutic drug monitoring,
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
January 1996,
Annales de biologie clinique,
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
November 1991,
Therapeutic drug monitoring,
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
December 1996,
Clinical biochemistry,
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
February 2004,
Therapeutic drug monitoring,
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
January 1987,
Lancet (London, England),
J A Karboski, and
P J Godley, and
P A Frohna, and
M W Horton, and
W J Reitmeyer
January 1990,
European journal of clinical pharmacology,
